Sector revisions Mesa Laboratories, Inc.

Stocks

Market Closed - Nasdaq 21:00:00 27/08/2026 BST			5-day change	1st Jan Change
128.65 ^USD	+1.18%		+7.97%	+63.89%

08-10	Mesa Laboratories, Inc., Q1 2027 Earnings Call, Aug 10, 2026
08-10	Tranche Update on Mesa Laboratories, Inc.'s Equity Buyback Plan announced on November 10, 2005.	CI

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	MESA LABORATORIES, INC.							2
	ABBOTT LABORATORIES							25
	MEDTRONIC PLC							25
	CENCORA, INC.							13
	HOYA CORPORATION							15
	BECTON, DICKINSON AND COMPANY							12
	DEXCOM, INC.							25
	MEDLINE INC.							26
	WEST PHARMACEUTICAL SERVICES, INC.							15
	TERUMO CORPORATION							13
	STERIS PLC							8
	SARTORIUS STEDIM BIOTECH							14
	ZIMMER BIOMET HOLDINGS, INC.							21
	SOLVENTUM CORPORATION							13
	FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED							11
	BAXTER INTERNATIONAL INC.							11
	ALIGN TECHNOLOGY, INC.							15
	GLOBUS MEDICAL, INC.							13
	BIO-RAD LABORATORIES, INC.							5
	REPLIGEN CORPORATION							20
	Average							15
	Weighted average by Cap.							19